Potential importance of dihydropyrimidine dehydrogenase (DPD) in cancer chemotherapy

Pharmacogenetics. 1994 Dec;4(6):301-6. doi: 10.1097/00008571-199412000-00002.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / pharmacokinetics*
  • Dihydrouracil Dehydrogenase (NADP)
  • Female
  • Fluorouracil / adverse effects
  • Fluorouracil / pharmacokinetics
  • Genetics, Population
  • Humans
  • Male
  • Neoplasms / drug therapy*
  • Neoplasms / enzymology*
  • Neoplasms / genetics
  • Oxidoreductases / deficiency
  • Oxidoreductases / genetics
  • Oxidoreductases / metabolism*
  • Purine-Pyrimidine Metabolism, Inborn Errors / enzymology
  • Purine-Pyrimidine Metabolism, Inborn Errors / genetics

Substances

  • Antineoplastic Agents
  • Oxidoreductases
  • Dihydrouracil Dehydrogenase (NADP)
  • Fluorouracil